News | February 02, 2012

Biotronik Completes Testing Connection for Home Monitoring to EHRs

February 2, 2011 – Biotronik has successfully completed its final interoperability testing process for Biotronik Home Monitoring, an Internet-based system for patient and implantable cardiac device information.

During the week of Jan. 9, Biotronik participated in the “Integrating the Healthcare Enterprise” (IHE) North American Connectathon in Chicago, Ill., to test its implantable device cardiac observation (IDCO) profile. This testing demonstrated the ability of Biotronik Home Monitoring to connect to third-party electronic health record (EHR) systems and cardiovascular data management systems using defined industry standards. The connecting technology from the Biotronik Home Monitoring system to the EHRs is called Biotronik EHR DataSync.

The conclusion from this successful testing is that Biotronik EHR DataSync will enable physicians and hospitals to share data seamlessly, which should increase productivity, eliminate redundant medical device management systems and improve clinical decision making and quality-of-care. In this round of testing, Biotronik proved the ability of Biotronik EHR DataSync to connect with widely implemented EHR vendor systems (e.g., Epic and Medical Micrographics), as well as emerging and established cardiovascular data management systems (e.g., ScottCare’s OneView CRM).

The IHE developed their testing process to promote the adoption of standards that enable healthcare information to be shared seamlessly across clinical settings. The IHE’s goals are to drive standards for interoperability, increase efficiency and reduce costs to healthcare customers, such as those in the cardiology, radiology and laboratory markets.

Implantable cardiac devices are also designed to capture and record information about medical device performance and patient heart rhythms that is vital to patient care. Biotronik Home Monitoring quickly organizes this information and allows data to be sent directly and securely to a clinic’s or a hospital’s EHR system. That data is then available to include in the patient’s personal health record.

“Electronic health records support efficient access to important patient healthcare information, so making this data readily available via secure data transport is vital,” said Jake Langer, president of Biotronik. “Streamlined connectivity to critical device and lead data is an increasingly important priority for physicians and the broader U.S. healthcare network, and therefore Biotronik made it a priority, too.”

Data integrity is guaranteed and has been proven through validation testing. Data security is ensured by using U.S. Commerce Department encryption methods. In addition, the Biotronik Home Monitoring system adheres to patient privacy standards and requirements for the electronic transmission of health information in accordance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) standards.

For more information: www.biotronik.com

 

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Overlay Init